US$ 21.62
equinox glp 1 GLP-1 weight loss drug marketing trends GLP-1 Tone System
Description
Colleen McCabe, PharmD, BCOP, and Lindsay Mundy, PharmD, BCOP, provided an engaging exploration of the benefits and potential pitfalls seen with the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in an oncology setting

Adult people (18 years) with a diagnosis of obesity (body mass index30 kg/m2) or T2DM (ICD-10-CM: E11) between 2018 and 2024 were subdivided in two mutually exclusive cohorts: (1) GLP-1 RA Users

It is designed as a non-constipation formula, providing support and promoting balance in digestive health

Top GLP-1 Tracking Apps: Why it matters